These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11255865)

  • 41. Progress treating, preventing influenza.
    Stephenson J
    JAMA; 1998 Nov; 280(20):1729-30. PubMed ID: 9842933
    [No Abstract]   [Full Text] [Related]  

  • 42. [Neuraminidase inhibitors oseltamivir and zanamivir: new means of defence against influenza].
    de Jong JC; Beyer WE; Rimmelzwaan GF; Fouchier RA; Osterhaus AD
    Ned Tijdschr Geneeskd; 2004 Jan; 148(2):73-9. PubMed ID: 14753128
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.
    Hayden FG; Osterhaus AD; Treanor JJ; Fleming DM; Aoki FY; Nicholson KG; Bohnen AM; Hirst HM; Keene O; Wightman K
    N Engl J Med; 1997 Sep; 337(13):874-80. PubMed ID: 9302301
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Virology. The origin and control of pandemic influenza.
    Laver G; Garman E
    Science; 2001 Sep; 293(5536):1776-7. PubMed ID: 11546857
    [No Abstract]   [Full Text] [Related]  

  • 45. Influenza in the family.
    Wright P
    N Engl J Med; 2000 Nov; 343(18):1331-2. PubMed ID: 11058679
    [No Abstract]   [Full Text] [Related]  

  • 46. Zanamivir to prevent influenza.
    Feder HM
    N Engl J Med; 2001 Feb; 344(7):528; author reply 529-30. PubMed ID: 11221617
    [No Abstract]   [Full Text] [Related]  

  • 47. Short-term treatment with zanamivir to prevent influenza: results of a placebo-controlled study.
    Kaiser L; Henry D; Flack NP; Keene O; Hayden FG
    Clin Infect Dis; 2000 Mar; 30(3):587-9. PubMed ID: 10722450
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influenza and the new antivirals: potential for misdiagnosis and possible misuse of antivirals.
    Lim S; Richardson D; Conly JM
    Can Commun Dis Rep; 2000 Dec; 26(23):202-5. PubMed ID: 11131689
    [No Abstract]   [Full Text] [Related]  

  • 49. [Influenza: from vaccine prevention to antiviral therapy].
    Nkoghe D; Scheen AJ
    Rev Med Liege; 2000 Jan; 55(1):19-23. PubMed ID: 10803033
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Zanamivir: from drug design to the clinic.
    Elliott M
    Philos Trans R Soc Lond B Biol Sci; 2001 Dec; 356(1416):1885-93. PubMed ID: 11779388
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Managing influenza: amantadine, rimantadine and beyond.
    Fleming DM
    Int J Clin Pract; 2001 Apr; 55(3):189-95. PubMed ID: 11351773
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Zanamivir. A potent and selective inhibitor of influenza A and B viruses.
    Aoki FY; Hayden FG
    Clin Pharmacokinet; 1999; 36 Suppl 1():v-ix. PubMed ID: 10429834
    [No Abstract]   [Full Text] [Related]  

  • 53. Oseltamivir resistance in influenza A (H5N1) infection.
    Gupta RK; Nguyen-Van-Tam JS
    N Engl J Med; 2006 Mar; 354(13):1423-4; author reply 1423-4. PubMed ID: 16571890
    [No Abstract]   [Full Text] [Related]  

  • 54. New influenza drugs zanamivir (Relenza) and oseltamivir (Tamiflu): unexpected serious reactions.
    Macdonald L
    CMAJ; 2000 Oct; 163(7):879-81, 883-5. PubMed ID: 11033723
    [No Abstract]   [Full Text] [Related]  

  • 55. The relentless flu drug.
    Environ Health Perspect; 1998 Aug; 106(8):A372-3. PubMed ID: 9867459
    [No Abstract]   [Full Text] [Related]  

  • 56. Evidence-based emergency medicine/systematic review abstract. Use of the neuraminidase inhibitor class of antiviral drugs for treatment of healthy adults with an acute influenza-like illness.
    Pitts SR
    Ann Emerg Med; 2002 May; 39(5):552-4. PubMed ID: 11973564
    [No Abstract]   [Full Text] [Related]  

  • 57. New application method of zanamivir with a straw.
    Imuta F; Toyoda M; Toyoda T
    Pediatr Int; 2003 Jun; 45(3):366-7. PubMed ID: 12828601
    [No Abstract]   [Full Text] [Related]  

  • 58. Does the availability of a neuraminidase inhibitor impair influenza vaccination? A report from Austria.
    Kunze U; Groman E; Vymazal K; Hartl HK
    Vaccine; 2001 Feb; 19(15-16):1854. PubMed ID: 11345055
    [No Abstract]   [Full Text] [Related]  

  • 59. Summaries for patients. Influenza vaccination or antiviral treatment for healthy working adults: an economic analysis.
    Ann Intern Med; 2002 Aug; 137(4):I22. PubMed ID: 12186536
    [No Abstract]   [Full Text] [Related]  

  • 60. Treating influenza with zanamivir. Management of Influenza in the Southern Hemisphere Trialists.
    Silagy CA
    Lancet; 1999 Feb; 353(9153):669. PubMed ID: 10030350
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.